In 2021, both Canadian and foreign investors closed overall larger venture capital deals than ever, resulting in an increasingly robust life science industry in Canada. In the Biotech – Therapeutics and Diagnostics sector alone, the three top financing deals were each worth at least 100 million USD.
For more details on the Biotechgate data, see our report, created in cooperation with our Partners Montréal InVivo and BioAlberta.